朱维铭
电话:邮箱:juwiming@nju.edu.cn 地址:研究方向:

胃肠外科、炎症性肠病综合治疗、临床营养支持治疗

  • 个人简介
  • 学术兼职
  • 代表性论文
  • 承担科研项目
  • 获奖情况

医学博士、主任医师、教授、博士生导师

南京大学医学院附属金陵医院普通外科主任

擅长复杂胃肠外科、炎症性肠病综合治疗及临床营养支持治疗


中华医学会外科学分会胃肠外科学组委员

中华医学会消化病分会炎症性肠病学组顾问

中华医学会肠外肠内营养学分会胃肠病与营养协作组组长


1.       Huang L, Qian W, Xu Y, et al. Mesenteric adipocyte contributes to intestinal fibrosis in Crohn’s disease through the ATX-LPA axis[J]. Journal of Crohn's and Colitis, 2022(7):7

2.       Guo Z, Zhu Y, Xu Y, et al. Endoscopic Evaluation at 1 Month After Ileocolic Resection for Crohn's Disease Predicts Future Postoperative Recurrence and Is Safe[J]. Diseases of the Colon & Rectum, 2022, 65(3): 382-389.

3.       Yin Y, Yang J, Pan Y, et al. Chylomicrons-simulating sustained drug release in mesenteric lymphatics for the treatment of Crohn’s-like colitis[J]. Journal of Crohn's and Colitis, 2021, 15(4): 631-646.

4.       Yin Y, Yang J, Pan Y, et al. Mesopore to macropore transformation of metal-organic framework for drug delivery in inflammatory bowel disease[J]. Advanced Healthcare Materials, 2021, 10(3): 20009

5.       Wang K, Huang L, Huang W, et al. Predictive Value of CT Enterography Index for Postoperative Intra-abdominal Septic Complications in Patients With Crohn’s Disease: Implications for Surgical Decision-Making[J]. Diseases of the Colon & Rectum, 2021, 64(8): 964-976.

6.       Liu R, Qiao S, Shen W, et al. Disturbance of Fatty Acid Desaturation Mediated by FADS2 in Mesenteric Adipocytes Contributes to Chronic Inflammation of Crohn’s Disease[J]. Journal of Crohn's and Colitis, 2020, 14(11): 1581-1599.

7.       Xu Y, Guo Z, Cao L, et al. Isolated colonic Crohn's disease is associated with a reduced response to exclusive enteral nutrition compared to ileal or ileocolonic disease[J]. Clinical Nutrition, 2019, 38(4): 1629-1635.

8.       Liu R, Guo Z, Cao L, et al. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn’s Disease[J]. Diseases of the Colon & Rectum, 2019, 62(3): 318-326.

9.       Shen W, Li Y, Zou Y, et al. Mesenteric Adipose Tissue Alterations in Crohn’s Disease Are Associated With the Lymphatic System[J]. Inflammatory Bowel Diseases, 2019, 25(2): 283-293.

10.    Shen W, Li Y, Cao L, et al. Decreased Expression of Prox1 Is Associated With Postoperative Recurrence in Crohn’s Disease[J]. Journal of Crohn's and Colitis, 2018, 12(10): 1210-1218.

Shen W, Cao L, Li Y, et al. Visceral fat is associated with mucosal healing of infliximab treatment in Crohn’s disease[J]. Diseases of the Colon & Rectum, 2018, 61(6): 706-712.


1.       国家自然科学基金(82170573)基于ATX-LPA轴探讨肠系膜脂肪细胞磷脂代谢异常在克罗恩病免疫紊乱中的作用(2022.01-2025.1255万元)

2.       国家自然科学基金(81770556)肠系膜脂肪细胞功能障碍在克罗恩病中的意义及HIF通路的调节作用(2018.01-2021.1256万元)

3.       国家自然科学基金(81570500)基于肠系膜淋巴内皮细胞探讨脂肪因子Apelin在克罗恩病中的作用及意义(2016.01-2019.1268.3万元)

4.       国家自然科学基金(81170365)应用CD52单抗(Campath)选择性清除淋巴细胞对克罗恩病的干预作用及其机制研究(2012.01-2015.1260万元)

国家自然科学基金(30972881)基于树突状细胞的TLR信号在克罗恩病时的变化及雷公藤甲素干预机制(2010.01-2012.1232万元)


以第一或第二贡献者身份获得省部级科技进步一等奖2项,二等奖2项,2010年国家科技进步一等奖《肠功能障碍的治疗》主要完成人之一。首届裘法祖普通外科医学青年奖获得者。